BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 15736109)

  • 1. Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement.
    Soares DV; Spina LD; de Lima Oliveira Brasil RR; da Silva EM; Lobo PM; Salles E; Coeli CM; Conceição FL; Vaisman M
    Metabolism; 2005 Mar; 54(3):321-9. PubMed ID: 15736109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency.
    Colao A; Di Somma C; Filippella M; Rota F; Pivonello R; Orio F; Vitale G; Lombardi G
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):360-6. PubMed ID: 15355453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency.
    Colao A; Di Somma C; Rota F; Pivonello R; Savanelli MC; Spiezia S; Lombardi G
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2056-62. PubMed ID: 15671089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common carotid intima-media thickness in growth hormone (GH)-deficient adolescents: a prospective study after GH withdrawal and restarting GH replacement.
    Colao A; Di Somma C; Rota F; Di Maio S; Salerno M; Klain A; Spiezia S; Lombardi G
    J Clin Endocrinol Metab; 2005 May; 90(5):2659-65. PubMed ID: 15713715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.
    Pfeifer M; Verhovec R; Zizek B; Prezelj J; Poredos P; Clayton RN
    J Clin Endocrinol Metab; 1999 Feb; 84(2):453-7. PubMed ID: 10022400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis.
    Colao A; Di Somma C; Spiezia S; Rota F; Pivonello R; Savastano S; Lombardi G
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2191-200. PubMed ID: 16537686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency.
    Szczepańiska Kostro J; Tołwińska J; Urban M; Gardziejczyk M; Głowińska B
    J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1405-13. PubMed ID: 15526719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency.
    Colao A; Di Somma C; Spiezia S; Savastano S; Rota F; Savanelli MC; Lombardi G
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3416-24. PubMed ID: 18593773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two years of growth hormone replacement therapy in a group of patients with Sheehan's syndrome.
    Soares DV; Spina LD; de Lima Oliveira Brasil RR; Lobo PM; Salles E; Coeli CM; Conceição FL; Vaisman M
    Pituitary; 2006; 9(2):127-35. PubMed ID: 16944044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
    Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
    Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease.
    Heikens J; Ubbink MC; van der Pal HP; Bakker PJ; Fliers E; Smilde TJ; Kastelein JJ; Trip MD
    Cancer; 2000 May; 88(9):2116-21. PubMed ID: 10813724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men.
    Wallenfeldt K; Bokemark L; Wikstrand J; Hulthe J; Fagerberg B
    Stroke; 2004 Oct; 35(10):2248-52. PubMed ID: 15345795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant human growth hormone therapy on blood lipid and carotid intima-media thickness in children with growth hormone deficiency.
    Chen M; Gan D; Luo Y; Rampersad S; Xu L; Yang S; Li N; Li H
    Pediatr Res; 2018 May; 83(5):954-960. PubMed ID: 29206809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of alendronate sodium on carotid artery intima-media thickness and lipid profile in women with postmenopausal osteoporosis.
    Celiloglu M; Aydin Y; Balci P; Kolamaz T
    Menopause; 2009; 16(4):689-93. PubMed ID: 19240658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters.
    Lanes R; Soros A; Flores K; Gunczler P; Carrillo E; Bandel J
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3978-82. PubMed ID: 15870123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency.
    Borson-Chazot F; Serusclat A; Kalfallah Y; Ducottet X; Sassolas G; Bernard S; Labrousse F; Pastene J; Sassolas A; Roux Y; Berthezène F
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1329-33. PubMed ID: 10199774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk.
    Abdu TA; Elhadd TA; Buch H; Barton D; Neary R; Clayton RN
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):387-93. PubMed ID: 15355457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults.
    Oliveira JL; Aguiar-Oliveira MH; D'Oliveira A; Pereira RM; Oliveira CR; Farias CT; Barreto-Filho JA; Anjos-Andrade FD; Marques-Santos C; Nascimento-Junior AC; Alves EO; Oliveira FT; Campos VC; Ximenes R; Blackford A; Parmigiani G; Salvatori R
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4664-70. PubMed ID: 17911170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.